Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inthaco, also known as the Inhalation Technology and Healthcare Advisory Company, was a specialized UK-based firm focused on the development of inhalation drug delivery systems. The company provided expert consultancy and technical services specifically for dry powder inhalers (DPIs) and respiratory formulations. Founded by Dr. David Harris, a recognized expert in the field, Inthaco supported pharmaceutical clients in optimizing the delivery of small molecules and other therapeutics to the lungs. In January 2007, the company was acquired by Vectura Group to strengthen its internal device development and formulation capabilities. Following the acquisition, Inthaco's expertise was integrated into Vectura's respiratory platform, which eventually became part of Philip Morris International.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inthaco.